Sam L. Barker, Director at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 1,000 shares at $5.00 ($5K) on 2021-08-24, disclosed to the SEC on 2021-08-25.
Open-market purchase of $5k CYCC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |
| CADX | BUY | 2011-05-11 | $63K | — | Filing → |